Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy. [electronic resource]
- Medicinal research reviews 09 2019
- 1447-1484 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1098-1128
10.1002/med.21557 doi
Antineoplastic Agents--therapeutic use Humans Ligands Neoplasms--metabolism Nod1 Signaling Adaptor Protein--chemistry Nod2 Signaling Adaptor Protein--chemistry Nucleotides--metabolism Polymerization Protein Conformation Signal Transduction